Частота определения и диагностическое значение антител к циклическому цитруллинированному пептиду (АЦЦП) и антител к модифицированному цитруллинированному виментину (АМЦВ) у детей с ранним ювенильным артритом
https://doi.org/10.14412/1995-4484-2008-494
Аннотация
Ключевые слова
Об авторах
С. О. СалугинаЕ. С. Федоров
E N Alexandrova
А. А. Новиков
А. А. Баранов
Ю. А. Валогина
М. В. Черкасова
T N Nikolaeva
N A Subova
Список литературы
1. <div><p>Кузьмина Н.Н., Салугина С.О., Никишина И.П. Ювенильный артрит — XXI век — как мы сегодня понимаем терминологические и классификационные аспекты? Научно-практич. ревматол., 2006, 4, 86-96.</p><p>Lawrence J.M. 3rd, Moore T.L., Osborn T.G. et al. Autoantibody studies in juvenile rheumatoid arthritis. Sem. Arthr. Rheum., 1993,22(4),265-74.</p><p>Gedalia A., Molina J.F., Garcia C.O. et al. Anticardiolipin antibodies in childhood rheumatic disorders. Lupus, 1998, 7(8), 551-553.</p><p>Serra C.R., Rodrigues S.H., Silva N.P. et at. Clinical significance oj' anticardiolipin antibodies in juvenile idiopathic arthritis. Clin. Exp. Rheumatol., 1999, 17(3),375-380.</p><p>Avcin Т., Ambmzic A., Bozic B. et al. Estimation of anticardiolipin antibodies, anti-ji2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Clin. Exp. Rheumatol., 2002, 20(1), 101108.</p><p>Cassidy J. T., Petty R. E. Juvenile Rheumatoid Arthritis, hi: Textbook of pediatric rheumatology. 4th Edition., 2002, 218.</p><p>Machado S. H., Carlos A. von Mulilen et al. The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. J. Pediatr. (Rio J.), 2005, 81(6), 491-494.</p><p>Чемерис H.A., Насонов ЕЛ. Диагностическое значение антител к циклическому цитруллинированному пептиду при ревматоидном артрите. Клинич. мед., 2005, 8,48-54.</p><p>Александрова Е.Н., Чемерис Н.А., Каратеев Д.Е. и др. Антитела к циклическому цитруллинированному пептиду при ревматоидном артрите. Тер. архив, 2004, 12, 64-68.</p><p>Rycke L., Реепе I., Hoffman l.E.A. et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann. Rheum. Dis., 2004, 63, 15871593.</p><p>Schellekens G.A., Visser H., de Jong B.A. et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthr. Rheum., 2000, 43, 155-163.</p><p>Jansen L.M., van Schaardenburg D., van der Horst- Bruinsma I. et al. The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. J. Rheumatol., 2003, 30(8), 1691-1695.</p><p>VallbrachtL, RieberJ., Oppermann M. etal. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann. Rheum. Dis., 2004, 63(9), 1079-1084.</p><p>Bizzaro N. Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis. Clin. Chem. Lab. Med., 2007, 45(2),150-157</p><p>Ales A., Karaaslan Y., Aksaray S. Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis. Clin. Rheumatol., 2007, 26(4), 499-504</p><p>Van Rossum М., van Soesbergen R., de Kort S. et al. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J.Rheumatol., 2003, 30(4), 825-828.</p><p>Low J.M., Chauhan A.K., Kietz D.A. et al. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. J. Rheumatol., 2004, 31,1829-1833</p><p>Avcin Т., Cimaz R-, Falcini F. et al. Prevalence and clinical significance of anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis Ann. Rheum. Dis., 2002, 61,608-611.</p><p>Mistry B.J., Faller G., Tikly M. Anti-cyclic citrullinated peptide: its prevalence and clinical significance in a South African cohort with juvenile idiopathic arthritis. 15"' European Paediatric Rheumatology Society Congress, London, UK, 14-17 September, 2008. Abstract Boole, p. 76.</p><p>Li В., Ye Z., Guo F. et at. Clinical significance of anti- cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis. I5'1' European Paediatric Rheumatology Society Congress, London, UK, 14-17 September, 2008. Abstract Book, p. 82.</p><p>Kasapcopur O., Altun S., Aslan M. et al. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann. Rheum. Dis., 2004, 63(12), 1687-1689.</p><p>Boehme М., Jouquan J., Blasehek M. etal. The prevalence of anti-cyclic citrullinated peptide antibodies in JIA. J.Pediatr., 2005, 81,491-494.</p><p>Kwok J.S., Hui K.H., Lee T.L. et al. Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Scand. J. Rheumatol., 2005, 34(5), 359-366.</p><p>FerucciE.D., Majka D.S., Parrish L.A. etal. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular- onset juvenile rheumatoid arthritis. Arthr. Rheum., 2005, 52(1), 239-46.</p><p>Brunner J., Sitzmann F.C. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthr. Clin. Exp. Rheumatol., 2006, 24(4), 449-451.</p><p>Gerloni V., Teruzzi B., Salmaso A. et al. Anti-cyclic citrullinated peptide antibodies (aCCP-Abs) in juvenile idiopathic arthritis (JIA): A monocentric prospective study of 369 patients cohort. 14"' European Paediatric Rheumatology Congress, Istambul, Turkey, 5- 9 September, 2007. Abstract Book, p. 185.</p><p>Hromadnikova I., Stechova K, Pavla V. et al. Anri- cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Autoimmunity, 2002, 35, 397-401.</p><p>Lee D.M., Schur P.H. Clinical utility of the anti- CCP assay in patients with rheumatic diseases. Ann. Rheum. Dis., 2003, 62, 870-874.</p><p>Dejaco C., Klotz W., Larcher H. et al. Diagnostic value of antibodies against a modified citrullinated vimentin in arthritis. Arthr. Res. Ther., 2006, 8,119.</p><p>Novikov A.A., Alexandrova E.N., Karateev D.E. et al. Diagnostic value of antibodies against a modified citrullinated vimentin, cyclic citrullinated peptide and IGM rheumatoid factor in early rheumatoid arthritis. Ann. Rheum. Dis., 2007,66,333</p><p>Hueber W., Hassfeld W., Smolen J. S. et al. Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis. Rheumatology, 1999,38, 155-159.</p><p>Hayem G., Chazerain P., Combe B. et al. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J.Rheumatol., 1999, 26, 7-13.</p><p>Ursum J., Nielen М., Schaardenburg D. et al. Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study. Arthr. Res. Ther., 2008, 10, R12.</p><p>Mathsson L., Mullazehi М., Wick M.C. et al. Antibodies against cirullinated vimentin in rheumatoid arthritis. Arthr. Rheum., 2008, I, 36-45.</p><p>Hassj'eld W.G., Vinje O., Konig K. et al. Autoantibodies to mutated citrullinated vimentin in juvenile rheumatoid arthritis Ann. Rheum. Dis., 2006, 65, suppl. II, 439 (abstract).</p><p>Guseinova D., Lasareva A., Shantere R. et al. The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis. IS'1 European Paediatric Rheumatology Society Congress, London, UK, 14-17 September, 2008. Abstract Book, p. 79.</p><p>Lamot L., Tesija Kuna A., Zirovic M. et al. The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis. 15"' European Paediatric Rheumatology Society Congress, London, UK, 14-17 September, 2008. Abstract Book, p. 79.</p><p>Shmerling R.H., Delbanco T.L. The rheumatoid factor: an analysis of clinical utility. Am. J.Med.,1991, 91,528-534</p></div><br />
Рецензия
Для цитирования:
Салугина С.О., Федоров Е.С., Alexandrova E.N., Новиков А.А., Баранов А.А., Валогина Ю.А., Черкасова М.В., Nikolaeva T.N., Subova N.A. Частота определения и диагностическое значение антител к циклическому цитруллинированному пептиду (АЦЦП) и антител к модифицированному цитруллинированному виментину (АМЦВ) у детей с ранним ювенильным артритом. Научно-практическая ревматология. 2008;46(6):74-80. https://doi.org/10.14412/1995-4484-2008-494
For citation:
Salugina S.O., Fedorov E.S., Alexandrova E.N., Novikov A.A., Baranov A.A., Valogina Y.A., Cherkasova M.V., Nikolaeva T.N., Subova N.A. Frequency and diagnostic significance of anti-cyclic citrullinated peptide antibodies (ACCP) and anti-modified citrullinated vimentin antibodies (AMCV) in children with early juvenile arthritis. Rheumatology Science and Practice. 2008;46(6):74-80. (In Russ.) https://doi.org/10.14412/1995-4484-2008-494
Просмотров: 6822
Послать статью по эл. почте 